Treatments for cancer include drugs that target dividing cells with the inevitable collateral consequence of compromising the immune system, that is, immunosuppression; thus short term exposure to a mAb in the treatment of cancers may not occasion the generation of ADA. This evidence concerns the gene ADA and cancer.